Investment
Features
FeesSafety
Academy
More
Pluang+

IKE Tech launches IKE 2.0 platform for continuous compliance in regulated products, starting with nicotine.

Others
28 Sep 2026
PRNewsWire
View Source
Bullish
IKE Tech launches IKE 2.0 platform for continuous compliance in regulated products, starting with nicotine.

IKE Tech LLC has launched IKE 2.0, a next-generation compliance platform designed to maintain accountability for regulated products throughout their lifecycle, from manufacture to point of use. Initially focused on the global nicotine market, the platform verifies user identity, authenticates products, applies configurable policies, and provides compliance intelligence beyond the point of sale. This addresses a major gap where current systems fail to track product use or authenticity after purchase. IKE 2.0 is modular, privacy-focused, and built on proven technology already deployed in nicotine regulation, with plans to expand into other regulated sectors like cannabis and healthcare.

The launch of IKE Tech's IKE 2.0 compliance platform comes as a backdrop to today's Technology sector performance on Pluang. For readers following Technology stocks, here is Pluang's market snapshot as of Sep 28, 2026 20:31 WIB: out of 150 priced US Technology stocks, 13 rose and 131 fell. Notable movers include ASAN (Asana Inc.) at USD 8.67 with a -3.88% change and a typical hold time of 35 days, AXTI (AXT Inc) at USD 76.00 down 3.72% with a 16-day hold, and EGHT (8x8 Inc) at USD 2.22 down 3.48% with a 15-day hold.

More News

Investigation launched into Quantum Computing Inc. officers for possible self-dealing breaches.

Investigation launched into Quantum Computing Inc. officers for possible self-dealing breaches.

Kuehn Law, PLLC is investigating whether certain officers and directors of Quantum Computing Inc. violated their fiduciary duties through potential self-dealing. This probe could lead to shareholder damages and corporate governance reforms. Long-term...

Market News
Bearish
4 hours ago
Grail's stock jumps 55% after positive FDA advisory vote on Galleri cancer test.

Grail's stock jumps 55% after positive FDA advisory vote on Galleri cancer test.

Grail's stock surged 55% in one week following a positive FDA advisory committee vote on its Galleri multi-cancer early detection test, which was deemed safe and beneficial. Analyst Kyle Mikson raised the price target from $80 to $150, reflecting str...

Analyst Insights
Bullish
4 hours ago
Akamai secures $11.6B Anthropic deal, shifting to AI and cloud infrastructure with strong growth outlook.

Akamai secures $11.6B Anthropic deal, shifting to AI and cloud infrastructure with strong growth outlook.

Akamai Technologies is evolving from a content delivery network provider to a leader in distributed cloud and AI infrastructure, highlighted by a landmark $11.6 billion deal with Anthropic. Its CIS segment grew 39% year-over-year in Q2 2026, with all...

Market News
Bullish
4 hours ago
$1,000 in Apple could grow to $1,621 by 2031, with a bull case near $1,952 and bear at $1,144.

$1,000 in Apple could grow to $1,621 by 2031, with a bull case near $1,952 and bear at $1,144.

Apple shares have risen over 33% in the past year, and a $1,000 investment today could be worth about $1,621 by 2031 in a base scenario, reflecting a 62% total return. The bull case projects the investment nearly doubling to $1,952, while the bear ca...

Company Fundamentals
Bullish
4 hours ago
ElevenLabs launches v4 speech models with faster voice cloning and support for 90+ languages

ElevenLabs launches v4 speech models with faster voice cloning and support for 90+ languages

ElevenLabs introduced its new v4 and v4 Turbo speech models, featuring faster voice cloning with just 10 seconds of audio, improved expression control, and support for over 90 languages. The models reduce latency for smoother voice agent interactions...

Others
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App